IMR Press / CEOG / Special Issues / 1637745047126

Screening and Diagnosis of Cervical Cancer

Submission deadline: 15 June 2022
Special Issue Editors
Roxana Elena Bohîlțea, MD, PhD
Department of Obstetrics and Gynecology, "Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Interests: Cervical and endometrial cancers; Preterm birth; Prenatal diagnosis; High-risk pregnancy; Nutrition and preventive medicine
Valentin Varlas, MD, PhD
Department of Obstetrics and Gynecology, "Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Interests: Pregnancy; Endometriosis; Hysterolaparoscopy
Special Issue Information

Dear Colleagues,

Most cases of cervical cancer can be prevented by effectively treating precancerous lesions detected by cervical screening.

In this Special Issue, we want to highlight the role of early diagnosis and screening programs for cervical cancer that affects an increasing number of patients. The lack or avoidance of screening programs contributes to the late diagnosis of this condition, sometimes in advanced stages, which significantly increases the risk of early recurrence and leads to an unfavorable prognosis. Another scenario, more common in young patients, is secondary to aggressive phenotypic forms of cervical cancer, which leads to detection in advanced stages of this cancer despite efforts to implement and comply with screening programs. Identifying risk factors for cervical cancer, and sexual practices that accelerate the process of carcinogenesis such as HPV infection with high-risk oncogenic strains may help select those groups of patients with a worse prognosis.

In this Special Issue, we hope to provide new information on early diagnosis and the implementation of screening programs for cervical cancer which will contribute to improved outcomes for these patients.

Roxana Elena Bohîlțea and Valentin Varlas

Guest Editors

Cancer screening
Cervical cancer screening programs
Pre-cancer cervical lesions
Human papillomavirus (HPV) test
Cervical cancer mortality
Pap smear
Liquid-based cytology
Immunocytochemistry (IHC)
Cervical intraepithelial neoplasia
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Open Access Original Research
Uterine Arteries Embolization—A Rescue Tool for Acute Vaginal Bleeding in Late Stages of Gynecologic Malignancies
Roxana Elena Bohîlțea, Bogdan Dorobaț, Maria Mădalina Doldur, Ana-Maria Cioca, ... Valentin Varlas
Clin. Exp. Obstet. Gynecol. 2022, 49(6), 142;
(This article belongs to the Special Issue Screening and Diagnosis of Cervical Cancer)
Back to top